Forecast: Basic Pharmaceutical Products Production Value in Spain

Since 2013, Spain's basic pharmaceutical products production value has demonstrated fluctuating growth. The production value increased from €2.77 billion in 2013 to €4.82 billion in 2023, representing a steady rise overall. Significant increases were noted in 2014, 2018, and 2020, with 16.35%, 21.67%, and 18.85% year-on-year growth, respectively. Recent years have shown more stable growth, such as 4.8% in 2022 and 4.53% in 2023. However, there were downturns observed, notably in 2017 and 2019, impacting the long-term average growth. Compounded annual growth rates (CAGR) reflect these trends, peaking in some years like 2022 at 6.77% and dipping in others. The forecast for the upcoming years indicates a consistent upward trajectory with a CAGR of 2.99%, reaching €5.82 billion in 2028.

Future trends to watch for include technological advancements in drug production, regulatory changes, and the impact of healthcare policies on pharmaceutical manufacturing. Additionally, investment in research and development, and the global pharmaceutical supply chain dynamics, will play crucial roles in shaping future production values.